Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

GPR141 Regulates Breast Cancer Progression via Oncogenic Mediators and The p-mTOR/p53 Axis

News

May 22, 2023
PRESS RELEASE: On May 19, 2023, a new research paper was published in Oncotarget, entitled, “G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis.” continue reading »

Targeting Cellular Respiration as a Therapeutic Strategy in Glioblastoma

News

May 19, 2023
PRESS RELEASE: On May 4, 2023, a new research perspective was published in Oncotarget, entitled, “Targeting cellular respiration as a therapeutic strategy in glioblastoma.” continue reading »

Automated, Accurate Reporting for NGS-Based Clonality Testing

News

May 16, 2023
PRESS RELEASE: On May 12, 2023, a new research paper was published in Oncotarget, entitled, “Development and implementation of an automated and highly accurate reporting process for NGS-based clonality testing.” continue reading »

Reaching the Brain Through the Groin: A Novel Approach to Brain Cancer

Trending

May 11, 2023
In a new editorial, researchers discuss opening the blood-brain barrier and a promising new strategy for the treatment of brain cancer. continue reading »

Using Cancer Proteomics Data to Identify Gene Candidates for Therapeutic Targeting

News

May 10, 2023
PRESS RELEASE: On May 4, 2023, a new research perspective was published in Oncotarget, entitled, “Using cancer proteomics data to identify gene candidates for therapeutic targeting.” continue reading »